Nestlé Health Science to Invest $65 Million in a Biotech Start-Up

From NY Times (1/6/15):

Nestlé Health Science to Invest $65 Million in a Biotech Start-Up
By Michael J. de la Merced

"Four years after opening for business, a subsidiary of Nestlé specializing in nutritional therapy is striking one of its most prominent investments to date with a bet on experimental treatments for the bacteria within the human body.

Nestlé Health Science plans to announce on Tuesday that it has invested $65 million in Seres Health, a start-up based in Cambridge, Mass., that focuses on restoring the “microbiome” — the host of microorganisms that provide vital functions for humans. The company’s current focus includes treatments for infectious diseases as well as metabolic and inflammatory illnesses...."
http://dealbook.nytimes.com/…/nestle-health-sciences-to-i…/…